AI assistant
BeOne Medicines Ltd. — Director's Dealing 2025
Jun 25, 2025
30073_dirs_2025-06-25_46af3660-75aa-4f5f-ae9a-403cc7795893.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BeOne Medicines Ltd. (ONC)
CIK: 0001651308
Period of Report: 2025-06-24
Reporting Person: Wang Xiaodong (Director, Chair, Scientific Advisory Brd)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-06-24 | American Depositary Shares | S | 300 | $263.50 | Disposed | 1707 | Direct |
| 2025-06-24 | American Depositary Shares | S | 1100 | $265.3525 | Disposed | 607 | Direct |
| 2025-06-24 | American Depositary Shares | S | 507 | $266.5653 | Disposed | 100 | Direct |
| 2025-06-24 | American Depositary Shares | S | 100 | $267.81 | Disposed | 0 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Ordinary Shares | 5154770 | Direct |
| Ordinary Shares | 1025063 | Indirect |
| Ordinary Shares | 3953100 | Indirect |
| Ordinary Shares | 50 | Indirect |
Footnotes
F1: These securities are held by a family trust, the beneficiaries of which are the Reporting Person's family members, for which the Reporting Person disclaims beneficial ownership.
F2: These securities are held by Wang Investment LLC, of which 99% of the limited liability company interest is owned by two grantor retained annuity trusts, of which the Reporting Person's wife is a trustee, for which the Reporting Person disclaims beneficial ownership.
F3: These securities are held by the spouse of the Reporting Person.
F4: Each American Depositary Share represents 13 Ordinary Shares.
F5: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted on August 12, 2024.
F6: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $263.40 to $263.55, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
F7: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $265.02 to $265.86, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
F8: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $266.27 to $266.95, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.